SUBSCRIBE
SUBSCRIBE
News   Policy

Mela Sciences Gets Long-Awaited FDA Date For Cancer Detection Device

August 17, 2010 | 
1 min read
MassDevice -- MELA Sciences Inc. finally gets a date with a Food & Drug Administration panel for its hand-held device, designed to obviate the need for skin biopsies of possible melanomas.
Regulatory
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Podcast
Gilead’s Ouro Buy, J&J/Protagonist’s Approval, Aurinia’s Revamp, ACIP Confusion, More
March 25, 2026
 · 
1 min read
 · 
Heather McKenzie
Adults hand drawing pathway for baby boy. Parent influence on child development and future. Parental control and support for growth and education of kid. vector
FDA
Rezolute Lauds ‘Unusual’ FDA Feedback Supportive of Path Forward for Hypoglycemia Drug
March 24, 2026
 · 
3 min read
 · 
Heather McKenzie
Focal seizure. Vector illustration of human brain and electroencephalograhy or EEG originating from temporal lobe.
Parkinson’s disease
FDA Warns of Seizure Risk With Some Parkinson’s Drugs
March 23, 2026
 · 
2 min read
 · 
Tristan Manalac
Businessman confuse others with jargon in speech bubble dialogue
FDA
9 Months In, FDA’s New Priority Voucher Program Still Clouded With Uncertainty
March 23, 2026
 · 
7 min read
 · 
Heather McKenzie